INM-004

N/A

Report date: 2024/12/23 15:23:02

Base Information

Drug NameINM-004
Drug Alias NameINM-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionShiga toxin inhibitors
TargetsShiga toxin
Therapy Area/IndicationsDiarrheaHemolytic-Uremic SyndromeKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumRomaniaItaly +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInmunova Sa
China Registration ClassN/A

Develop Information

Active CompaniesInmunova Sa
Inactive CompaniesN/A
Active IndicationsHemolytic-Uremic Syndrome
Inactive IndicationsDiarrheaKidney Diseases

Other Information

ATC CodeN/A
Related LinksDrugBank